Amiodarone induced retrobulbar neuritis. Report of one case;Neuritis retrobulbar inducida por amiodarona. Caso clínico

Revista Medica de Chile

Volumn 127, Issue 7, 1999, Pages 827-830

  Bartolucci J, Jorge ^a,b   Ibáñez L, Patricio ^a   Verdugo J, Cecilia ^a   Fuentes G, René ^a   Arriagada G, Gaspar ^a   Torres M, Jorge ^a  

^a UNIVERSIDAD DE VALPARAÍSO   (Chile)

^b NONE   (Chile)

Author keywords

Amiodarone; Drug adverse effects; Neuritis; Subnormal; Vision

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; HEART ATRIUM FIBRILLATION; HUMAN; MALE; OPTIC NEURITIS; PAROXYSMAL TACHYCARDIA;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HUMANS; MALE; OPTIC NEURITIS; TACHYCARDIA, PAROXYSMAL;

EID: 0033154707     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. TISDALE J, FOLLIN S, ORDELOVA A, WEBB C. Risk factors for development of specific noncardiovascular adverse effects associated with amiodarone. J Clin Pharmacol 1995; 35: 351-6.
2. WILSON JJ, PODRID PJ. Side effects amiodarone. Am Heart J 1991; 121: 158-71.
3. PATHE M, KHAN JC. Does amiodarone have a benefit effect on mortality? Presse Med 1991; 20: 1330-4.
4. BELEC L, DÁVILA G, BLEIDEL JM, AZUOLAY A, LALOUN L, POISSON M. Bilateral optic neuropathy during prolonged treatment with amiodarona. Ann Med Interne Paris 1992; 143: 349-50.
5. FREEDMAN MD, SOMBERG JC. Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol. 1991; 31: 1061-9.
6. LAKHDAR AA, FARISH E, HILLIS WS, DUNN FG. Long term amiodarone therapy raises serum cholesterol. Eur J Clin Pharmacol 1991; 40: 477-80.
7. GILL J, HEEL RC, FITTON A. Amiodarone An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs 1992; 43: 69-110.
8. FAJURI A, RODRÍGUEZ J, GONZÁLEZ R, JALIL J, GARCÍA E, MOLGO M, VALENZUELA P. Efficacy and secondary effects of chronic treatment with amiodarone. Rev Méd Chile 1993; 121: 516-22.
9. ANDERSON EN, LYNCH NM, O'BRIEN KP. Disabling neurological complications of amiodarona. Aust NZJ Med 1985; 15: 300-4.
10. CHARNESS ME, MORADY F, SCHEINMAN MM. Frequent neurologic toxicity associated with amiodarone therapy. Neurology 1984; 34: 669-71.
11. RAEDER EA, PODRID PJ, LOWN B. Side effects and complications of amiodarone therapy. Am Heart J 1985; 109: 975-83.
12. JAANUS SD. Ocular side effects of selected systemic drugs. Optom-Clinic 1992; 2: 73-96.
13. HARRIS L. Unwanted effects. In Harris L, amiodarone. Roncucci R (eds). Paris, Medsi 1986; 204-69.
14. a Edición. Editorial Mc Graw Hill 1998; 487.
15. LEIBOLD JE. Drugs have a toxic effect on the optic nerve? Int Ophtalmol Clin 1971; 11: 137-45.
16. SHUKLA R, JOWETT NI, THOMPSON DR, POHL JE. Side effects with amiodarone therapy. Postgrad Med J 1994; 70: 492-8.